The effect of Inhaled Nicotine on Pulmonary Surfaces
The effect of Inhaled Nicotine on Pulmonary Surfaces
批准号:
10083514
负责人:
Mehmet Kesimer
金额:
$6.29万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-06 至 2021-11-30
关键词:
AcuteAffectAntiinflammatory EffectAntimicrobial EffectBiologicalBloodBronchiectasisCardiovascular DiseasesCellsChronicChronic Obstructive Airway DiseaseDataDiseaseDrug KineticsElectronic cigaretteEpithelialEpitheliumEscalatorGeneral PopulationGlycerolGrantHealthHumanHydration statusImpairmentIn VitroInhalationInternationalJournalsKnowledgeLeukocyte ElastaseLungMalignant neoplasm of lungMass Spectrum AnalysisMeasuresMetabolicMetabolismMetalloproteasesMucinsMusNicotineNicotinic ReceptorsParentsPatientsPeer ReviewPeptide HydrolasesPharmacodynamicsPhasePlayProcessPropertyPropylene GlycolsProteinsProteomicsPublicationsPublishingPulmonary EmphysemaResearchResearch PersonnelRespiratory SystemRoleSamplingScientistSmokingSputumStructureSurfaceSystemTestingTobaccoToxic effectToxinUrineVegetablesWestern BlottingWritingabsorptionaddictionairway epitheliumantimicrobialbasebiophysical techniquesbronchial epitheliumcell typedefense responsedesignelectronic cigarette useexperimental studyhuman subjectin vitro testinginterestmeetingsmortalityneutrophilnicotine inhalationnicotine useparent grantpathogenpulmonary functionvapervaping
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
In the parent grant, we have proposed to study the effect of nicotine on pulmonary surfaces. That is, we have
proposed to look at the effects of nicotine on key components of innate defense relevant to the lung using a
variety of cell biological and biophysical techniques. We have subsequently requested a revision to the grant to
include human subjects so that we can also study the effects of nicotine on innate defense cells derived from
humans including neutrophils. In the interim however, we have identified a major knowledge gap, namely that
we do not fully appreciate the levels of nicotine that occur in vapers’ lungs during and after vaping. This is an
impediment to our research since we do not know which concentrations of nicotine to add to our in vitro
experiments. Thus, in this supplement, Dr. Abdelwahab will measure nicotine levels in vaped humans and mice
and will also perform pharmacokinetic studies of nicotine on pulmonary surfaces in vitro. These studies will be
important not only for our research but for other researchers in the field since the knowledge does not exist.
Deciding how to perform the pharmacokinetics will be an iterative process and Dr. Abdelwahab will have
intellectual input into how and when to collect nicotine. He will also decide how to measure nicotine using mass
spectrometry-type approaches and will design the experiments to determine how long nicotine stays around on
airway surfaces. These studies will enable Dr. Abdelwahab to develop independent as a scientist since they will
allow him to design and execute important experiments that will be of international interest. Moreover, should
these experiments be successful, it is also fully expected that he will have the opportunity to present these data
at national and international meetings and to write them up for publication in peer-reviewed journals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core B: Mucus/Mucin Analytics Core
-
批准号:10684187
-
项目类别:
-
资助金额:$26.83万
-
财政年份:2022
-
负责人:Mehmet Kesimer
-
依托单位:
The effect of Inhaled Nicotine on Pulmonary Surfaces
-
批准号:10089471
-
项目类别:
-
资助金额:$55.72万
-
财政年份:2017
-
负责人:Mehmet Kesimer
-
依托单位:
The effect of Inhaled Nicotine on Pulmonary Surfaces
-
批准号:9234295
-
项目类别:
-
资助金额:$45.6万
-
财政年份:2017
-
负责人:Mehmet Kesimer
-
依托单位:
Core B: Analytics for Mucolytics Core
-
批准号:10001595
-
项目类别:
-
资助金额:$32.19万
-
财政年份:2017
-
负责人:Mehmet Kesimer
-
依托单位:
Airway mucus/mucin composition and proteome in COPD: A SPIROMICS ancillary study
-
批准号:8521361
-
项目类别:
-
资助金额:$35.22万
-
财政年份:2011
-
负责人:Mehmet Kesimer
-
依托单位:
Airway mucus/mucin composition and proteome in COPD: A SPIROMICS ancillary study
-
批准号:8215467
-
项目类别:
-
资助金额:$33.82万
-
财政年份:2011
-
负责人:Mehmet Kesimer
-
依托单位:
Airway mucus/mucin composition and proteome in COPD: A SPIROMICS ancillary study
-
批准号:8323313
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2011
-
负责人:Mehmet Kesimer
-
依托单位:
Airway mucus/mucin composition and proteome in COPD: A SPIROMICS ancillary study
-
批准号:8688051
-
项目类别:
-
资助金额:$36.26万
-
财政年份:2011
-
负责人:Mehmet Kesimer
-
依托单位:
The role of mucin-protein interactions in the innate defense of the lung
-
批准号:8656401
-
项目类别:
-
资助金额:$35.9万
-
财政年份:2010
-
负责人:Mehmet Kesimer
-
依托单位:
The role of mucin-protein interactions in the innate defense of the lung
-
批准号:8116579
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2010
-
负责人:Mehmet Kesimer
-
依托单位:
The role of mucin-protein interactions in the innate defense of the lung
-
批准号:8252157
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2010
-
负责人:Mehmet Kesimer
-
依托单位:
The role of mucin-protein interactions in the innate defense of the lung
-
批准号:7946676
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2010
-
负责人:Mehmet Kesimer
-
依托单位:
The role of mucin-protein interactions in the innate defense of the lung
-
批准号:8463602
-
项目类别:
-
资助金额:$34.87万
-
财政年份:2010
-
负责人:Mehmet Kesimer
-
依托单位:
Project 1: The Effects of New and Emerging Tobacco Products on Lung Hyd
-
批准号:9328120
-
项目类别:
-
资助金额:$57.44万
-
财政年份:--
-
负责人:Mehmet Kesimer
-
依托单位:
Project 1: The Effects of New and Emerging Tobacco Products on Lung Hyd
-
批准号:8595538
-
项目类别:
-
资助金额:$65.27万
-
财政年份:--
-
负责人:Mehmet Kesimer
-
依托单位:
Project 1: The Effects of New and Emerging Tobacco Products on Lung Hyd
-
批准号:8737947
-
项目类别:
-
资助金额:$57.27万
-
财政年份:--
-
负责人:Mehmet Kesimer
-
依托单位:
海外基金